Literature DB >> 15155547

Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity.

Muneaki Hidaka1, Ken-ichi Fujita, Tetsuya Ogikubo, Keishi Yamasaki, Tomomi Iwakiri, Manabu Okumura, Hirofumi Kodama, Kazuhiko Arimori.   

Abstract

There has been very limited information on the capacities of tropical fruits to inhibit human cytochrome P450 3A (CYP3A) activity. Thus, the inhibitory effects of tropical fruits on midazolam 1'-hydroxylase activity of CYP3A in human liver microsomes were evaluated. Eight tropical fruits such as common papaw, dragon fruit, kiwi fruit, mango, passion fruit, pomegranate, rambutan, and star fruit were tested. We also examined the inhibition of CYP3A activity by grapefruit (white) and Valencia orange as controls. The juice of star fruit showed the most potent inhibition of CYP3A. The addition of a star fruit juice (5.0%, v/v) resulted in the almost complete inhibition of midazolam 1'-hydroxylase activity (residual activity of 0.1%). In the case of grape-fruit, the residual activity was 14.7%. The inhibition depended on the amount of fruit juice added to the incubation mixture (0.2-6.0%, v/v). The elongation of the preincubation period of a juice from star fruit (1.25 or 2.5%, v/v) with the microsomal fraction did not alter the CYP3A inhibition, suggesting that the star fruit did not contain a mechanism-based inhibitor. Thus, we discovered filtered extracts of star fruit juice to be inhibitors of human CYP3A activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155547     DOI: 10.1124/dmd.32.6.581

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

1.  Isolation of cytochrome P450 3A (CYP3A) inhibitors from Hyuganatsu, Citrus tamurana Hort.

Authors:  Shinzo Hosoi; Eri Shimizu; Noriyuki Usami; Ikuo Yamamoto; Kazuhiko Arimori; Manabu Okumura; Muneaki Hidaka; Mitsuko Yamada; Akiyo Sakushima
Journal:  J Nat Med       Date:  2006-04-14       Impact factor: 2.343

2.  Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats.

Authors:  Aliyah Almomen; Hadir M Maher; Nourah Z Alzoman; Shereen M Shehata; Amal Alsubaie
Journal:  PeerJ       Date:  2020-09-22       Impact factor: 2.984

3.  Analysis of CYP3A inhibitory components of star fruit (Averrhoa carambola L.) using liquid chromatography-mass spectrometry.

Authors:  Shinzo Hosoi; Eri Shimizu; Kazuhiko Arimori; Manabu Okumura; Muneaki Hidaka; Mitsuko Yamada; Akiyo Sakushima
Journal:  J Nat Med       Date:  2008-03-25       Impact factor: 2.343

4.  Antidotal activity of Averrhoa carambola (Star fruit) on fluoride induced toxicity in rats.

Authors:  Rupal A Vasant; A V R L Narasimhacharya
Journal:  Interdiscip Toxicol       Date:  2014-11-15

Review 5.  Nutritional, Medicinal and Toxicological Attributes of Star-Fruits (Averrhoa carambola L.): A Review.

Authors:  Narmataa Muthu; Su Yin Lee; Kia Kien Phua; Subhash Janardhan Bhore
Journal:  Bioinformation       Date:  2016-12-22

6.  Effects of tomato juice on the pharmacokinetics of CYP3A4-substrate drugs.

Authors:  Atsuko Ohkubo; Tomomi Chida; Hidetomo Kikuchi; Tadashi Tsuda; Katsuyoshi Sunaga
Journal:  Asian J Pharm Sci       Date:  2017-05-12       Impact factor: 6.598

Review 7.  A Practical Perspective on the Use of Botanicals During the COVID-19 Pandemic: From Proven to Potential Interactions.

Authors:  Alexander Bertuccioli; Marco Cardinali; Francesco Di Pierro; Simone Magi; Giordano Zonzini
Journal:  J Med Food       Date:  2021-11-17       Impact factor: 2.786

8.  A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat.

Authors:  Gurbet Celik; Aslı Semiz; Serdar Karakurt; Sevki Arslan; Orhan Adali; Alaattin Sen
Journal:  Biomed Res Int       Date:  2013-07-18       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.